Difficulty: Medium
Average Score: 82%
Practice
A pregnant woman is scheduled to undergo chorionic villus sampling (CVS) based on genetic family history. Which medication does the nurse anticipate will be administered?
Correct answer
C
Rationale
In the context of maternal monitoring, the correct answer is C) RhoGAM if the patient is Rh-negative. Chorionic villus sampling (CVS) is a prenatal test that involves taking a small sample of cells from the placenta to check for genetic conditions. If a pregnant woman is Rh-negative and the fetus is Rh-positive, there is a risk of Rh incompatibility which can lead to hemolytic disease of the newborn. Administering RhoGAM to an Rh-negative mother can prevent her from developing antibodies against Rh-positive blood, thus protecting future pregnancies.
Option A) Magnesium sulfate is commonly used to prevent seizures in preeclampsia or eclampsia, not routinely administered for CVS procedures.
Option B) Prostaglandin suppository is not indicated for CVS. Prostaglandins are often used for cervical ripening or induction of labor.
Option D) Betamethasone is a corticosteroid given to pregnant women at risk of preterm delivery to help accelerate fetal lung maturity. It is not typically administered in the context of CVS for genetic testing.
Educationally, understanding the rationale behind administering RhoGAM in Rh-negative pregnant women undergoing procedures like CVS is essential for nurses and healthcare providers involved in maternal monitoring. It highlights the importance of preventing Rh incompatibility issues that can affect the health of both the current and future pregnancies. This knowledge ensures appropriate and timely interventions to promote maternal and fetal well-being.
Option A) Magnesium sulfate is commonly used to prevent seizures in preeclampsia or eclampsia, not routinely administered for CVS procedures.
Option B) Prostaglandin suppository is not indicated for CVS. Prostaglandins are often used for cervical ripening or induction of labor.
Option D) Betamethasone is a corticosteroid given to pregnant women at risk of preterm delivery to help accelerate fetal lung maturity. It is not typically administered in the context of CVS for genetic testing.
Educationally, understanding the rationale behind administering RhoGAM in Rh-negative pregnant women undergoing procedures like CVS is essential for nurses and healthcare providers involved in maternal monitoring. It highlights the importance of preventing Rh incompatibility issues that can affect the health of both the current and future pregnancies. This knowledge ensures appropriate and timely interventions to promote maternal and fetal well-being.